Commercial Strategy Workshop #4: Bio-pharmaceutical Asset Valuation

Date: October 27, 2018 @ 4:30 pm – @ 5:30 pm
Location: Hanqi Investment, 1633 Bayshore Hwy, Unit 280, Burlingame, CA 94010

Dear CABS members and non-members,

It is my great pleasure to invite you to the next long overdue Commercial Strategy Workshop. The mission of these series of workshops is to provide an overview of the business decision making process in the commercializing of new therapeutics and medical devices. These workshops will be valuable to anyone interested in learning more about the business side of life sciences and potential career paths. 

This workshop will focus on valuing a pre-commercial bio-pharmaceutical asset. We will be examining the framework and methodologies in which private equity and corporate development teams look at and conduct due diligence on clinical stage assets. Specifically, we will be covering:

  • Market opportunity assessment frameworks
  • Forecast structure inputs for net revenue
  • NPV analysis methodology

This workshop will be useful for anyone who's ever been curious on how acquisition prices for pre-revenue molecules come to be, or more broadly how the buy-side thinks about clinical stage assets. The content will be introductory and very much a "valuation 101"; no prior experience in forecasting or due diligence is needed to attend. 

Sincerely yours,

Anthony Hsiao

Business and Career Development Committee

free online registration – $0 (USD)